European practices of genetic information and insurance: Lessons for the genetic information nondiscrimination act

JAMA

Volumn 300, Issue 3, 2008, Pages 326-327

  Van Hoyweghen, Ine ^a   Horstman, Klasien ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACT; CLINICAL PRACTICE; EUROPE; EXPERIENCE; GENETIC INFORMATION NONDISCRIMINATION ACT; INSURANCE; NOTE; PRIORITY JOURNAL;

EID: 47549098987     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2008.62     Document Type: Note

References (15)

1. Wadman M. Genetics bill cruises through Senate. Nature. 2008;453(7191):9.
2. Hampton T. Congress passes bill to ban discrimination based on individuals' genetic makeup. JAMA. 2008;299(21):2493.
3. Hudson KL. Prohibiting genetic discrimination. N Engl J Med. 2007;356 (20):2021-2023.
4. Collins F. The threat of genetic discrimination to the promise of personalized medicine. Testimony before the Subcommittee on Health, Committee on Energy and Commerce, United States House of Representatives hearing on HR 493, the Genetic Information Nondiscrimination Act of 2007. http://www.genome.gov/ 10001350. March 9, 2007. Accessed May 20, 2008.
5. Van Hoyweghen I. Risks in the Making: Travels in Life Insurance and Genetics. Amsterdam, the Netherlands: Amsterdam University Press; 2007.
6. Godard B, Raeburn S, Pembrey M, Bobrow M, Farndon P, Aymé S. Genetic information and testing in insurance and employment: technical, social and ethical issues. Eur J Hum Genet. 2003;11(suppl 2):S123-S142.
7. Alper JS, Beckwith J. Distinguishing genetic from non-genetic medical tests: some implications for anti-discrimination legislations. Sci Eng Ethics. 1998;4(2):141-150.
8. Morrison PJ. Insurance, unfair discrimination, and genetic testing. Lancet. 2005;366(9489):877-880.
9. Van Hoyweghen I, Horstman K, Schepers R. Making the normal deviant: the introduction of predictive medicine in private insurance. Soc Sci Med. 2006;63(5):1225-1235.
10. Swiss Reinsurance Co. Too Big to Ignore: The Impact of Obesity on Mortality Trends. London, England: Swiss Reinsurance Co; 2004.
11. Swiss Reinsurance Co. Smoking, Alcohol and Life Insurance: A Mortality Study by Swiss Re. London, England: Swiss Reinsurance Co; 1994.
12. SCOR Group. Smokers/non smokers: establishing differential rates. SCOR Technical Newsletters. 2002;5:1-4.
13. Munich Re Group. Is the Obesity "Epidemic" Stopping the Trend Towards Longevity? Munich, Germany: Munich Re Group; 2007.
14. Van Hoyweghen I, Horstman K, Schepers R. Genetic "risk carriers" and lifestyle "risk takers": which risks deserve our legal protection in insurance? Health Care Anal. 2007;15(3):179-193.
15. Van Hoyweghen I. Genetics and insurance: new technologies, new policies, new responsibilities. In: de Vries G, Horstman K, eds. Genetics From Laboratory to Society: Societal Learning as an Alternative to Regulation. London, England: Palgrave Macmillan; 2008:118-137.